Transtracheal oxygen, nasal CPAP and nasal oxygen in five patients with obstructive sleep apnea.

The effect of transtracheal oxygen administration by means of a 9-French (2.7 mm) percutaneous catheter was assessed in five patients with severe obstructive sleep apnea. We hypothesized that the delivery of oxygen below the site of airway obstruction should reduce the arterial oxygen desaturation during apneas and hypopneas, thereby increasing respiratory stability. Standard sleep and respiratory measurements were recorded in these subjects with all-night polysomnography on nonconsecutive nights during four experimental conditions: room air (BL), nasal continuous positive airway pressure (CPAP), nasal O2 (NC O2), and transtracheal O2 (TT O2). In three of these subjects, room air was infused (TT RA) at flow rates comparable to TT O2. Compared with baseline room air measurements, TT O2 not only significantly increased the SaO2 nadir from 70.4 percent to 89.7 percent (p less than 0.01), but it also reduced the frequency of sleep apnea/hypopnea from 64.6 to 26.2/h sleep (p less than 0.01). NC O2 ameliorated desaturation during apnea/hypopnea (mean SaO2 nadir, 86.2 percent; p less than .01) but did not significantly alter frequency (59.0/h sleep). Nasal CPAP was the most effective means of reducing sleep apnea/hypopnea (13.8/h sleep) but did not abolish desaturations when apneas occurred (mean SaO2 nadir, 80.0 percent). Compared with oxygen, transtracheal infusion of room air appeared to be somewhat effective; however, the small number of studies with TT RA precluded statistical analysis. We believe that TT O2 is superior to NC O2 for some patients with obstructive sleep apnea because continuous oxygen flow below the site of airway obstruction more reliably prevents alveolar hypoxia and respiration is stabilized. Infusion of air or oxygen through the tracheal catheter flow may also increase mean airway pressure and reduce obstructive apnea similar to nasal CPAP. We conclude that TT O2 may be an effective alternative mode of therapy for some patients with severe sleep apnea/hypopnea when nasal CPAP is not tolerated or when combined oxygen and nasal CPAP are required.

Ear oximetry to detect apnea and differentiate rapid eye movement (REM) and non-REM (NREM) sleep. Screening for the sleep apnea syndrome.

Ear oximetry is commonly employed in screening patients for the sleep apnea syndrome, but the lack of objective information regarding the duration of sleep, including the presence of rapid-eye-movement (REM) sleep, is a major limitation. Based on the premise that both apnea and sleep-state-dependent changes in ventilation give rise to distinctive patterns in the arterial oxygen saturation, we developed a systematic technique to analyze ear oximetric tracings for wakefulness, REM sleep, and non-REM (NREM) sleep. Fifty-four patients were studied by both all-night polysomnography and ear oximetry. A careful comparison of ear oximetric data for sleep states and apnea was then made, using polysomnography as the correct classification to determine sensitivity, specificity, predictive value positive, and predictive value negative of the ear oximetric tracings. When classification of sleep state was compared, ear oximetry correctly classified 280.5 (82 percent) of 340.9 hours of sleep that was either REM or NREM sleep. The sensitivity for classifying NREM sleep was 0.85, for REM sleep was 0.70, and for wakefulness was 0.49. The sensitivity by ear oximetry for apnea was 0.80, with a predictive value negative of 0.87. We conclude that although polysomnography must be performed for definitive evaluation, ear oximetry is a valuable screening test for sleep apnea because the presence or absence of apnea can be determined, total duration of sleep can be estimated, and NREM vs REM sleep can be differentiated.

Nasal continuous positive airway pressure devices do not maintain the set pressure dynamically when tested under simulated clinical conditions.

STUDY OBJECTIVES: Nasal continuous positive airway pressure (CPAP) is standard therapy for obstructive sleep apnea syndrome. The effective nasal mask pressure may be adversely affected by factors that increase system resistance (eg, long tubing and/or water condensation) and by dynamic variables (breathing frequency [f] and tidal volume [VT]). The present study was conducted in order to assess the performance of CPAP machines throughout a range of simulated clinical conditions. DESIGN: Four currently used CPAP machines were tested at settings of 5, 10, 15, and 20 cm H(2)O using a pulmonary waveform generator to produce VTs of 0.4, 0.8, and 1.2 L at frequencies of 10, 20, and 30 breaths/min. Machines were tested under five conditions: 6-foot and 12-foot tubing, with and without an in-line humidifier, and 12-foot tubing with humidifier and water condensation. MEASUREMENTS: Maximum and minimum mask pressure measurements were obtained during five respiratory cycles for each dynamic variable under each of the five conditions and CPAP settings (180 experiments on each of four CPAP models). RESULTS: Using typical clinical parameters (VT, 0.4 L and 0.8 L; f, 10 breaths/min and 20 breaths/min; and CPAP, 5 to 15 cm H(2)O), mask pressure consistently varied above and below the set point when additional tubing and/or a humidifier were added to the system (0.7 to 2.9 cm H(2)O below and 0.5 to 1.0 cm H(2)O above the set pressure). Water condensation caused large pressure deviations (inspiratory pressure ranged from 3.5 to 5.6 cm H(2)O below set pressure, and expiratory pressure ranged from 0.7 to 3.5 cm H(2)O above set pressure). CONCLUSIONS: Therapy and compliance could be adversely affected because some CPAP machines in current use do not maintain constant continuous mask pressure when tested using simulated conditions, especially when water condenses in the tubing.

Office management of common sleep-wake disorders.

The prevalence of sleep disorders manifest as insomnia and fatigue of excessive daytime sleepiness in the general population; office practice is high. Poor quality sleep may pose a significant health risk for not only the patient but society in general. Sensitivity for potentially serious sleep disorders should be coupled with an organized approach to diagnosis and therapy. Differentiation of the principal complaint into insomnia versus hypersomnia and determination of duration are the key elements. Office-based management of the most common sleep-wake disorders and current diagnostic testing standards are discussed.

Rebreathing pulmonary capillary and tissue volume in normals after saline infusion.

A rebreathing technique was utilized to assess changes in diffusing capacity (DCO), pulmonary capillary blood volume (Vc), pulmonary parenchymal tissue volume (Vt), and cardiac output (Qc), after infusion of 2 liters of 0.9% saline intravenously in 13-25 min in five healthy subjects. Blood hemoglobin concentration decreased an average of 17%. Vc increased strikingly in all five subjects. No significant changes in Vt, or in Vt per unit lung volume were observed. Radiographic evidence of interstitial pulmonary edema was present in four of the five subjects. Radiographic total lung capacity was reduced significantly in four of the five subjects. Significant reductions in forced vital capacity (FVC), forced expiratory volume in 1.0 and 3.0 s, and mean forced expiratory flow during the middle half of the FVC occurred in three of the five subjects. No dyspnea, cough, or physical examination abnormalities of lungs or heart occurred. This noninvasive, ventilation-limited, rebreathing technique appears capable of detecting early changes in pulmonary congestion, at a time when definitive radiographic changes and changes in the physical examination are absent. It appears capable of detecting the increase in Vc associated with hypervolemia in man.

Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.

Pulmonary reactions may follow therapy with nitrogen mustard, vincristine, procarbazine, and prednisone. Two patients with Hodgkin's disease are described who were treated with nitrogen mustard, vincristine, procarbazine, and prednisone and developed diffuse lung disease. Their disease processes were evaluated with serial pulmonary function studies, chest radiography, and open lung biopsy. Hypersensitivity reactions appeared to be responsible, and treatment with corticosteroids was successful. Procarbazine may have been the responsible agent.

Oxygen therapy: appropriate use of nebulizers.

Control of the inspired O2 concentration requires both an appropriate O2 fraction from the nebulizer and an adequate flow of gas to the patient. We evaluated the O2 fraction and total flow of commercially available nebulizers operated under conditions commonly encountered in clinical use. Total gas flow O2 fraction, and back pressure were measured in 8 commercially available nebulizers. Measurements were made with no outlet tubing ,with 72 inches of dry corrugated plastic tubing, and with 72 inches of corrugated plastic tubing partially occluded with water. Nebulizers were studied individually ,and in parallel sets of 2 and 3, at both 40% and 70% O2 settings. Total flow was always lower and O2 fraction higher than that predicted by the manufacture under all experimental circumstances. As the outlet resistance of the nebulizers increased, the O2 fraction increased and the total flow decreased. The O2 fraction was, in addition, increased with the addition of each nebulizer in parallel. Currently available nebulizers have operating characteristics that do not permit the easy administration of accurate O2 therapy.

A decision-driven system to collect the patient history.

We have developed a computer-administered history designed to directly interview hospitalized patients with pulmonary disease. A frame-based decision system is used to direct the history and to generate a one- to five-member differential diagnostic list based on this history. This system incorporates a cognitive model of question selection and a Bayesian scoring algorithm. Structures to control the choice of questions are embedded in the diagnostic frames and in a QUERY program that makes the final choice of questions. We have compared the behavior of this decision-driven approach with a history taken using a paper questionnaire. The paper-based history presents 182 questions to every patient and captured 75% of 85 pulmonary diseases in its differential lists. The decision-driven system asks 50.7 +/- 31.0 (mean +/- standard deviation) and captured 74% of 61 pulmonary diseases. Our experience suggests that the use of a computerized diagnostic knowledge base to direct the selection of pertinent questions can substantially reduce the number of questions necessary to collect a diagnostically useful patient history.